Welcome Message

We are honoured and delighted to welcome you all to the “17th International Conference on Human Genomics and Genomic Medicine” scheduled on November 21-22, 2024 at Dubai, UAE, with the theme “Towards a Healthier Future: Discover the Practical Applications of Genomics in Medicine”

HUMAN GENOME 2024 conference is an opportunity to network with doctors, professors, scientists, geneticists, genomic specialists, educationalists, renowned speakers, researchers, and students from all over the world who have interest in sharing their research experience and practical knowledge within the arena of Human Genomics and Genomic Medicine to a most exciting and memorable scientific meeting to announce and witness the recent scientific and technological advancements in Human Genomics and Genomic Medicine.

About Conference

Sessions and Tracks

Track 1: Human Genetics and Genomics

"Human genetics and genomics" is a field of study focused on understanding the genetic makeup of humans and how genetic variations contribute to traits, diseases, and overall health. It involves the study of genes, which are segments of DNA that encode specific proteins or regulate gene expression, as well as the broader genome, which encompasses all the genetic material in an organism. Overall, human genetics and genomics play a crucial role in advancing our understanding of human biology, disease mechanisms, and the development of novel therapeutic interventions and personalized medicine approaches.

Significant areas of research in human genetics and genomics include:

• Genome structure and function
• Genetic variation
• Mendelian genetics
• Complex traits and diseases
• Population genetics
• Genomic technologies
• Clinical genetics

Track 2: Pharma Genomics & Pharma Informatics

Pharmacogenomics and pharmacoinformatics are two important fields within the broader realm of pharmaceutical science.

Pharmacogenomics: Pharmacogenomics focuses on understanding how an individual's genetic makeup influences their response to drugs. It involves studying how genetic variations affect drug metabolism, efficacy, and adverse reactions. By analyzing a patient's genetic profile, pharmacogenomics aims to personalize drug therapy, allowing for more effective and safer treatments tailored to an individual's genetic characteristics. This field has the potential to optimize drug selection, dosage, and treatment strategies, leading to improved therapeutic outcomes and reduced adverse effects. Pharmacogenomics is particularly relevant in areas such as oncology, psychiatry, and cardiology, where genetic factors strongly influence drug response.

Pharmacoinformatics: Pharmacoinformatics integrates principles of computer science, statistics, and information technology with pharmaceutical research and development. It involves the application of computational methods and data analysis techniques to drug discovery, development, and clinical practice. Pharmacoinformatics encompasses various areas, including drug design and virtual screening, molecular modeling and simulation, bioinformatics, and systems pharmacology. By utilizing computational approaches, pharmacoinformatics accelerates the drug discovery process, facilitates the prediction of drug-target interactions and pharmacokinetic properties, and aids in the identification of potential drug candidates. It also plays a crucial role in managing and analyzing large-scale biological and chemical data sets, such as genomic and proteomic data, to extract meaningful insights for drug development and personalized medicine.

Track 3: Genomic Medicine

Genomic Medicine, also known as Medicine genomics or personalized medicine, refers to the use of genomic information to guide medical decisions, treatments, and healthcare practices.  It involves genomic testing, disease risk assessment, pharmacogenomics, precision treatment, cancer genomics, and ethical considerations. This approach enables personalized, targeted, and more effective approaches to disease prevention, diagnosis, and treatment. Overall, genomic medicine holds immense promise for advancing healthcare by enabling personalized, targeted, and more effective approaches to disease prevention, diagnosis, and treatment.

• Genomic testing
• Disease risk assessment
• Pharmacogenomics
• Precision treatment and therapy
• Cancer genomics
• Ethical and regulatory considerations

Track 4: Genes and Immunology

Genes play a fundamental role in immunology, influencing various aspects of the immune system's function, including its development, regulation, and response to pathogens. The genetic basis of immunology is essential for elucidating the mechanisms underlying immune responses, identifying therapeutic targets for immune-related disorders, and developing personalized approaches to immunotherapy and vaccination. Advances in genomic technologies, such as high-throughput sequencing and genome editing, continue to deepen our understanding of the complex interplay between genes and the immune system.

Genes intersect with immunology includes:

• Genetic basis of immune system development
• Immune receptor genes
• Major histocompatibility complex genes
• Cytokine genes
• Genetic susceptibility to diseases
• Pharmacogenomics of immunomodulatory drugs

Track 5: Human Gene Therapy

Human gene therapy involves the delivery of genetic material into a patient's cells to treat or prevent diseases by correcting or replacing abnormal or missing genes. This therapeutic approach holds great potential for treating a wide range of genetic disorders, as well as certain acquired diseases such as cancer.

Human gene therapy can be categorized into different types based on its objectives and methods:

• Gene replacement therapy
• Gene augmentation therapy
• Gene editing therapy
• Immunotherapy

Human gene therapy faces challenges related to safety, efficacy, and delivery methods. Ongoing research and clinical trials are focused on addressing these challenges and advancing gene therapy as a viable treatment option for a wide range of diseases.

Track 6: Genetically Modified Organisms

Genetically modified organisms (GMOs) are organisms whose genetic material has been altered using genetic engineering techniques. These modifications may involve the introduction of genes from other organisms or the modification of existing genes to achieve desired traits or characteristics. GMOs can encompass a wide range of organisms, including plants, animals, and microorganisms and they are used in various fields such as agriculture, medicine, industry, and research, and they have been developed for purposes such as pest resistance, disease resistance, improved nutritional content, and environmental sustainability. Despite their potential benefits, GMOs have also been the subject of controversy and public debate due to concerns about potential risks to human health, environmental impact, biodiversity, and socioeconomic issues.

• Genetic engineering techniques
• Applications in agriculture
• Regulation and labelling

Track 7: Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) is a reproductive technology used to screen embryos for genetic abnormalities before they are implanted in the uterus during in vitro fertilization (IVF). PGD enables couples at risk of passing on genetic disorders to conceive embryos that are free from the specific genetic condition they carry. It also raises complex ethical considerations related to embryo selection, non-medical applications, access to care, and reproductive autonomy.

Applications of Preimplantation Genetic Diagnosis (PGD) includes

• Prevention of genetic disorders
• Family balancing
• Reduced risk of genetic disorders
• Increased pregnancy success rates

Track 8: Infectious Diseases

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, fungi, parasites, or prions that can spread from person to person, from animals to humans, or through environmental exposure. These diseases affect individuals differently depending on various factors such as age, immune status, vaccination status, and underlying health conditions. These diseases can range from mild and self-limiting to severe and life-threatening. Understanding the biology, epidemiology, and prevention of infectious diseases is crucial for mitigating their impact on human health and well-being.

• Transmission
• Types of infectious agents (bacteria, viruses, fungi, parasites, prions)
• Epidemiology
• Prevention and control
• Emerging and re-emerging diseases
• Global health impact

Track 9: Cancer Genomics

Cancer genomics focuses on understanding the genetic basis of cancer and how genomic alterations contribute to the development, progression, and treatment response of tumors. It plays a crucial role in advancing our understanding of cancer biology, improving patient stratification, and facilitating personalized treatment approaches in oncology. Continued research in this field holds promise for furthering precision medicine and improving outcomes for cancer patients.

• Genetic alterations in cancer
• Genomic profiling
• Subtypes and molecular signatures
• Precision oncology
• Resistance mechanisms
• Liquid biopsies
• Clinical implications

Track 10: Emergency Genomic Medicine

Emergency genomic medicine refers to the integration of genomic information and technologies into emergency medical care to improve diagnosis, treatment, and outcomes for patients in urgent situations. Genomic medicine involves the study of an individual's genetic information, including their DNA sequence, and how it influences their health and response to diseases and treatments.

In emergency situations, genomic information can be precious for several reasons:

• Rapid diagnosis
• Precision medicine
• Risk assessment
• Family screening
• Research and innovation

However, implementing genomic medicine in emergency settings presents several challenges, including the need for rapid and accurate genomic testing, interpretation of complex genetic data, integration of genomic information into clinical decision-making processes, and addressing ethical and privacy considerations.

Track 11: Genomic Approach to Drug Discovery

The genomic approach to drug discovery involves utilizing genomic information and technologies to identify potential drug targets, develop new therapeutics, and personalize treatment regimens. This approach also facilitates the discovery of biomarkers that can aid in patient stratification and treatment selection, leading to personalized medicine approaches. Additionally, advances in genomic technologies, such as next-generation sequencing and genome editing tools like CRISPR-Cas9, have revolutionized drug discovery by enabling rapid and precise manipulation of genetic material for target validation and drug screening.

• Target identification
• Drug target validation
• Drug screening
• Genomic analysis of drug response
• Pharmacogenomics
• Drug repurposing

Track 12: Bioinformatics

Bioinformatics is an interdisciplinary field that combines biology, computer science, mathematics, and statistics to analyze and interpret biological data, particularly data derived from genomic and molecular biology research. It encompasses a wide range of techniques, algorithms, and tools used to analyze biological data, including DNA sequences, protein structures, gene expression patterns, and evolutionary relationships. It plays a critical role in advancing our understanding of genetics, genomics, proteomics, and other areas of molecular biology, as well as in applications such as drug discovery, personalized medicine, and agriculture.

• Data analysis
• Genomic sequencing
• Functional genomics
• Proteomics and structural biology
• Phylogenetics and evolutionary biology
• Drug discovery and design
• Personalized medicine
• Data integration and visualization

Track 13: Drug Detection & Development in Bioinformatics

Drug detection, it often refers to identifying the presence of drugs or their metabolites in biological samples such as blood, urine, or hair for various purposes including forensic analysis, drug testing, or monitoring medication adherence. Bioinformatics plays a central role in accelerating the drug discovery and development process by leveraging computational techniques to analyze biological data, prioritize drug targets, design novel compounds, predict drug efficacy and safety, and optimize clinical trial strategies.

Bioinformatics contributes to different stages of drug detection and development:

• Target identification and validation
• Drug screening and design
• Pharmacogenomics
• Drug repurposing
• Drug toxicity prediction
• Clinical trial optimization
• Data integration and systems biology

Track 14: Genome Mapping

Genome mapping is the process of identifying and determining the location of genes and other specific sequences of DNA within an organism's genome. It provides a blueprint of an organism's genetic makeup and is essential for understanding its structure, function, and evolution. Genome mapping involves techniques such as genetic mapping and physical mapping, as well as the use of high-throughput DNA sequencing technologies to generate comprehensive maps of genomes. This mapping plays a crucial role in various fields of biology and medicine, providing insights into the genetic basis of traits, diseases, and evolutionary processes. Continued advancements in genome mapping technologies and analyses are driving discoveries that have implications for personalized medicine, agriculture, conservation, and other areas of scientific research.

Applications of genome mapping include

• Identifying genetic variants associated with diseases
• Studying cancer genomics
• Comparative genomics
• Human genome

Track 15: Epigenetics Biomarkers

Epigenetic biomarkers are molecular signatures that reflect changes in the epigenome, which are modifications to DNA or associated proteins that regulate gene expression without altering the underlying DNA sequence. These biomarkers provide valuable insights into the dynamic regulation of gene activity in health and disease. These biomarkers have diverse applications in biomedical research and clinical practice, including disease diagnosis, prognosis, prediction of treatment response, and monitoring disease progression.

Types of Epigenetic Modifications includes

• DNA methylation
• Histone modifications
• Chromatin accessibility

Track 16: Computational Biology

Computational biology applies computational and mathematical methods to analyze and model biological systems. It encompasses a wide range of techniques and approaches for processing, interpreting, and integrating biological data, with the goal of gaining insights into complex biological phenomena. It plays a central role in advancing biological systems, driving discoveries in molecular biology and biomedicine, and accelerating the development of novel therapeutics and diagnostics. Continued advancements in computational methods, data analysis techniques, and computational resources are expected to further enhance ability to model, simulate, and predict complex biological processes.

• Data analysis
• Sequence analysis
• Structural biology
• Systems biology
• Genome informatics
• Network analysis
• Machine learning and artificial intelligence
• Data integration and visualization

Track 17: Cognitive Computing

Cognitive computing is an interdisciplinary field that combines artificial intelligence (AI), machine learning, natural language processing, and other advanced technologies to mimic human cognitive functions. It aims to create computer systems that can learn, reason, understand natural language, and interact with humans in a more natural and intelligent way. It represents a significant advancement in AI and has the potential to transform how humans interact with technology, make decisions, and solve complex problems. As the field continues to progress, it will likely play a key role in shaping the future of technology and society.

• Mimicking human intelligence
• Artificial intelligence and machine learning
• Natural language processing
• Context awareness
• Human-computer interaction

Track 18: Genomic Vaccination

Genomic vaccination, also known as DNA vaccination or genetic vaccination is a novel approach to vaccine development that involves the use of genetic material, such as DNA or RNA, to stimulate an immune response against a specific pathogen. Unlike traditional vaccines, which typically contain weakened or inactivated forms of pathogens or their components, genomic vaccines deliver genetic instructions (e.g., DNA or RNA) encoding antigenic proteins directly into cells. Genomic vaccination represents a promising approach to vaccine development, offering advantages in speed, flexibility, and safety.

Advantages:

• Speed and flexibility
• Induction of cellular and humoral immunity
• Safety

Applications:

• Infectious diseases
• Cancer immunotherapy

Track 19: Genomic Technologies in Forensic Science

Genomic technologies have revolutionized forensic science by providing powerful tools for analyzing DNA evidence with unprecedented sensitivity, accuracy, and efficiency. These technologies enable forensic scientists to extract valuable information from biological samples recovered from crime scenes, aiding in the identification of suspects, victims, and missing persons, as well as the resolution of criminal investigations. These technologies continue to advance, offering new opportunities for forensic investigation and justice.

Here are some key genomic technologies used in forensic science:

• PCR (Polymerase chain reaction)
• Capillary electrophoresis
• Next-generation sequencing (NGS)
• DNA profiling and databases
• Forensic DNA phenotyping
• Y-chromosome analysis

Track 20: Bioethics and Genomic Research

Bioethics plays a crucial role in guiding genomic research, which involves the study of an organism's complete set of DNA, or genome. Genomic research holds immense promise for advancing understanding of genetics, disease mechanisms, and personalized medicine. bioethics provides a framework for addressing the complex ethical challenges arising from genomic research and ensuring that scientific advances are pursued in a manner that upholds the principles of respect for persons, beneficence, justice, and respect for community values and norms. However, it also raises complex ethical considerations related to privacy, consent, data sharing, discrimination, and the equitable distribution of benefits.

 Some key ethical issues in genomic research:

• Informed consent
• Privacy and confidentiality
• Data sharing and access
• Genetic discrimination
• Equity and justice
• Commercialization and patenting
• Community engagement and consultation
• Reproductive and genetic technologies

Track 21: Education and Training in Genomic Medicine

Education and training in genomic medicine are essential to prepare healthcare professionals to integrate genomics into clinical practice effectively. These programs are essential to equip healthcare professionals with the knowledge, skills, and competencies needed to deliver personalized and precision medicine based on genomic information. Genomic medicine encompasses the use of genomic information to guide personalized medical care, including disease prevention, diagnosis, treatment, and prognosis. By investing in education and training programs, healthcare systems can ensure that genomic medicine becomes an integral part of patient-centered care and improves health outcomes for individuals and populations.

Some crucial aspects of education and training in genomic medicine include:

• Basic genomics education
• Clinical genomics training
• Continuing education and professional development
• Interdisciplinary collaboration
• Ethical, legal, and social implications
• Patient education and counselling
• Research training
• Healthcare system integration

Market Analysis

HUMAN GENOME 2024 is the best platform for all recognized/ under- recognized scholastics health specialists, geneticist, genomic specialists, analysts, educational scientists, industry researchers, scientists in the field of Human Genomics, to exchange about research and developments in grounds of Human Genomics and Genomic Medicine. The main focus of this meeting is to invigorate and globalize new thoughts and researches for treatment and to determine the current market for proceeding towards future of Genomic Medicines, operational devices, and diagnostics, with an accentuation on new technology that will be advantageous in the field of Human Genomics.

Genomic medicine is the field of medicine that uses genomic information to provide customized healthcare to patients. It contains the study of an individual’s genetic makeup & how it affects their health and response to medications. Genomic testing can provide information that can be utilized to diagnose genetic disorders & develop specified treatment plans. The market for genomic medicine has surged rapidly in recent years and is anticipated to continue further.

Global Genomic Medicine Market size is expected to be worth around USD 123.9 Billion by 2032 from USD 26.8 Billion in 2022, growing at a CAGR of 17% during the forecast period from 2023 to 2032.

This growth is propelled by factors like the growing prevalence of chronic disease, advances in genomic technologies, as well as a growing demand to personalize medicine. The genomic medicine market includes numerous products and services which include genomic sequencing, genetic tests, and personalized medicine treatments.

This is owing to the rising demand for the use of genomics in drug development. The market is also surged by the growing adoption of spatial genomics & transcriptomics technologies. Many trials are being conducted to find novel drugs using genomics. Also, the increasing incidence of chronic diseases such as cancer, cardiovascular disease, and diabetes has led to an increased demand for genome medicine in pharmaceutical & Biotechnology companies.